Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
4.51 CHF
6.26 B CHF
48.08 B CHF
1.48 B
About AstraZeneca PLC
Sector
Industry
CEO
Pascal Soriot
Website
Headquarters
Cambridge
Founded
1913
ISIN
GB0009895292
FIGI
BBG007FJNLY7
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company’s history roots back to the year 1913 when Astra business was formed. AstraZeneca was founded in 1999 through the merger of Astra AB and Zeneca Group PLC. The company is headquartered in Cambridge, the United Kingdom.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where AZN is featured.
Frequently Asked Questions
The current price of AZN is 81.00 CHF — it hasn't changed in the past 24 hours. Watch AstraZeneca PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange AstraZeneca PLC stocks are traded under the ticker AZN.
We've gathered analysts' opinions on AstraZeneca PLC future price: according to them, AZN price has a max estimate of 191.83 CHF and a min estimate of 116.00 CHF. Watch AZN chart and read a more detailed AstraZeneca PLC stock forecast: see what analysts think of AstraZeneca PLC and suggest that you do with its stocks.
AZN stock is 0.00% volatile and has beta coefficient of 1.01. Track AstraZeneca PLC stock price on the chart and check out the list of the most volatile stocks — is AstraZeneca PLC there?
Today AstraZeneca PLC has the market capitalization of 182.43 B, it has increased by 0.26% over the last week.
Yes, you can track AstraZeneca PLC financials in yearly and quarterly reports right on TradingView.
AstraZeneca PLC is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
AZN earnings for the last quarter are 1.72 CHF per share, whereas the estimation was 1.71 CHF resulting in a 0.44% surprise. The estimated earnings for the next quarter are 1.84 CHF per share. See more details about AstraZeneca PLC earnings.
AstraZeneca PLC revenue for the last quarter amounts to 11.47 B CHF, despite the estimated figure of 11.19 B CHF. In the next quarter, revenue is expected to reach 11.77 B CHF.
AZN net income for the last quarter is 2.00 B CHF, while the quarter before that showed 2.65 B CHF of net income which accounts for −24.54% change. Track more AstraZeneca PLC financial stats to get the full picture.
AstraZeneca PLC dividend yield was 2.35% in 2024, and payout ratio reached 69.15%. The year before the numbers were 2.15% and 73.66% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 29, 2025, the company has 94.3 K employees. See our rating of the largest employees — is AstraZeneca PLC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AstraZeneca PLC EBITDA is 15.79 B CHF, and current EBITDA margin is 33.02%. See more stats in AstraZeneca PLC financial statements.
Like other stocks, AZN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AstraZeneca PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AstraZeneca PLC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AstraZeneca PLC stock shows the buy signal. See more of AstraZeneca PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.